<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cai Z</submitter><funding>National Natural Science Foundation of China</funding><pagination>4251-4257</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9049068</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(8)</volume><pubmed_abstract>Long-term administration of chemotherapeutic agents often leads to multiple drug resistance (MDR), which greatly impairs the treatment outcome. To overcome this problem, a biodegradable nanocarrier based on an acid-sensitive calcium phosphate/silica dioxide (CAP/SiO&lt;sub>2&lt;/sub>) composite was constructed for the codelivery of drug and siRNA. Anticancer drug doxorubicin (DOX) was encapsulated into the composite scaffold by interacting with the exposed Ca&lt;sup>2+&lt;/sup> of CAP/SiO&lt;sub>2&lt;/sub> to achieve high drug loading (180 μg mg&lt;sup>-1&lt;/sup>). With further decoration of siRNA, the nanocarrier was applied to enhance the therapeutic efficacy by silencing MDR-relevant genes (P-gp) of DOX-resistance K562/ADR cancer cells. Benefiting from the intrinsic acid degradability of CAP/SiO&lt;sub>2&lt;/sub>, </pubmed_abstract><journal>RSC advances</journal><pubmed_title>pH-sensitive CAP/SiO&lt;sub>2&lt;/sub> composite for efficient co-delivery of doxorubicin and siRNA to overcome multiple drug resistance.</pubmed_title><pmcid>PMC9049068</pmcid><funding_grant_id>21775070</funding_grant_id><funding_grant_id>21475057</funding_grant_id><pubmed_authors>Jiang LP</pubmed_authors><pubmed_authors>He Z</pubmed_authors><pubmed_authors>Zhang Y</pubmed_authors><pubmed_authors>Cai Z</pubmed_authors><pubmed_authors>Chen Y</pubmed_authors><pubmed_authors>Wu X</pubmed_authors></additional><is_claimable>false</is_claimable><name>pH-sensitive CAP/SiO&lt;sub>2&lt;/sub> composite for efficient co-delivery of doxorubicin and siRNA to overcome multiple drug resistance.</name><description>Long-term administration of chemotherapeutic agents often leads to multiple drug resistance (MDR), which greatly impairs the treatment outcome. To overcome this problem, a biodegradable nanocarrier based on an acid-sensitive calcium phosphate/silica dioxide (CAP/SiO&lt;sub>2&lt;/sub>) composite was constructed for the codelivery of drug and siRNA. Anticancer drug doxorubicin (DOX) was encapsulated into the composite scaffold by interacting with the exposed Ca&lt;sup>2+&lt;/sup> of CAP/SiO&lt;sub>2&lt;/sub> to achieve high drug loading (180 μg mg&lt;sup>-1&lt;/sup>). With further decoration of siRNA, the nanocarrier was applied to enhance the therapeutic efficacy by silencing MDR-relevant genes (P-gp) of DOX-resistance K562/ADR cancer cells. Benefiting from the intrinsic acid degradability of CAP/SiO&lt;sub>2&lt;/sub>, </description><dates><release>2020-01-01T00:00:00Z</release><publication>2020 Jan</publication><modification>2025-04-21T16:48:29.011Z</modification><creation>2025-04-21T16:48:29.011Z</creation></dates><accession>S-EPMC9049068</accession><cross_references><pubmed>35495266</pubmed><doi>10.1039/c9ra07894k</doi></cross_references></HashMap>